Nephroblastoma - a 25 year review of a South African unit by Visser, Yolandi Thelma et al.
1	  
Nephroblastoma	  -­‐	  A	  25-­‐year	  review	  of	  a	  South	  African	  unit	  
Nephroblastoma	  at	  a	  South	  African	  hospital	  Yolandi	  Thelma	  Visser	  MB	  ChB,	  DCH	  ,	  Ronelle	  Uys	  MB	  ChB,	  	  Anel	  van	  Zyl	  MB	  ChB,	  M	  Med(Paed),	  FC	  Paed(SA),	  CMO(SA),	  	  Daniela	  Cristina	  Stefan	  MD,	  M	  Med(Paed),	  FC	  Paed(SA),	  CMO(SA),	  MSc(UK),	  PhD	  
Department	  of	  Paediatrics	  and	  Child	  Health,	  Stellenbosch	  University,	  Faculty	  of	  Health	  Sciences,	  Tygerberg	  Hospital	  
Corresponding	  author:	  Prof.	  DC	  Stefan,	  PO	  Box	  19063,	  Department	  of	  Paediatrics	  and	  Child	  Health,	  Tygerberg	  Hospital	  and	  Stellenbosch	  University,	  Tygerberg,	  Cape	  Town	  7550	  South	  Africa.	  Physical	  Address:	  Francie	  van	  Zijl	  Avenue,	  Clinical	  Building,	  2nd	  Floor,	  Room	  2091A,	  Tygerberg	  Campus,	  Western	  Cape,	  South	  Africa	  
	   2	  
Abstract	  Rationale:	  To	  determine	  the	  outcome	  of	  patients	  with	  nephroblastoma	  in	  a	  South	  African	  hospital	  Objective:	  To	  determine	  if	  there	  is	  a	  difference	  in	  the	  outcome	  of	  patients	  with	  nephroblastoma	  comparing	  two	  treatment	  protocols	  SIOP	  (Société	  International	  D’Oncologie	  Pédiatrique	  Protocol)	  versus	  NWTS	  (National	  Wilms’	  Tumour	  Study	  Protocol))	  Methods	  and	  results:	  A	  retrospective	  audit	  of	  children	  diagnosed	  with	  nephroblastoma	  at	  Tygerberg	  Hospital	  over	  25	  years	  (1983-­‐2007).	  One	  hundred	  and	  seven	  patients	  were	  included	  in	  the	  study	  and	  98	  analysed	  .The	  average	  age	  at	  diagnosis	  was	  3.8	  years.	  Most	  patients	  (37%)	  presented	  with	  stage	  1	  disease,	  followed	  by	  patients	  with	  stage	  3	  (27%).	  Most	  patients	  were	  treated	  according	  to	  the	  SIOP	  protocol	  (61%).	  Gender	  and	  race	  did	  not	  influence	  the	  outcome.	  Patients	  with	  stage	  1	  and	  2	  disease	  had	  the	  best	  outcome	  (76%	  versus	  43%	  for	  stages	  3	  and	  4).	  The	  SIOP	  group	  had	  a	  better	  outcome	  than	  the	  NWTS	  group	  (p	  value	  0.001).	  The	  two	  groups	  had	  an	  equal	  distribution	  of	  stage	  of	  presentation.	  The	  tumour	  volumes	  were	  bigger	  in	  the	  NWTS	  group	  (1004cm3	  compared	  to	  613cm3).	  Nutritional	  status	  did	  not	  influence	  the	  outcome	  although	  more	  patients	  were	  underweight	  for	  age	  in	  the	  SIOP	  group.	  Statistical	  methods	  used	  were:	  Kaplan	  Meier,	  Gehan’s	  Wilcoxon	  Test,	  Chi	  –square	  test	  and	  the	  Fisher	  exact	  test	  
	  
Discussion	  	  Contrary	  to	  other	  studies,	  patients	  treated	  according	  to	  the	  SIOP	  protocol	  had	  a	  statistically	  significant	  better	  outcome.	  Larger	  collaborative	  studies	  are	  needed	  to	  investigate	  this	  result	  in	  Africa.	  Key	  words:	  nephroblastoma;	  Wilms	  tumor;	  Africa;	  treatment	  protocols;	  outcome	  Abbreviations:	  SIOP	  (Société	  International	  D’Oncologie	  Pédiatrique	  Protocol);	  NWTS	  (National	  Wilms’	  Tumour	  Study	  Protocol)	  	  
Introduction	  	  Childhood	  cancers	  are	  rare,	  comprising	  about	  1%	  of	  all	  cancers.	  Nephroblastoma	  or	  Wilms	  tumour	  (WT)	  accounts	  for	  6-­‐7%	  of	  all	  childhood	  cancers1	  and	  is	  the	  most	  common	  renal	  tumour	  in	  childhood.	  	  In	  2010,	  data	  from	  the	  tumour	  registry	  of	  the	  South	  African	  Children’s	  Cancer	  Study	  Group	  (SACCSG)	  showed	  that	  WT	  was	  the	  fourth	  most	  common	  childhood	  cancer	  in	  South	  Africa2.	  Major	  improvements	  in	  the	  diagnosis	  and	  treatment	  of	  childhood	  cancers	  over	  the	  last	  50	  years	  have	  resulted	  in	  a	  high	  cure	  rate	  of	  approximately	  90%	  in	  developed	  countries.1	  Sadly,	  the	  success	  rate	  is	  far	  lower	  in	  South	  Africa	  and	  other	  developing	  countries,	  mostly	  due	  to	  a	  delay	  in	  seeking	  medical	  attention	  or	  to	  a	  lack	  of	  access	  to	  health	  care1	  or	  due	  to	  optimal	  therapy	  not	  being	  available3.	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Race	  disparities	  have	  been	  studied	  in	  the	  past;	  in	  2011	  a	  study	  by	  Jason	  et	  al	  found	  that	  African	  people	  had	  a	  higher	  incidence	  of	  WT	  than	  Caucasians.	  	  African	  patients	  were	  79%	  more	  likely	  to	  develop	  WT	  than	  Caucasian	  patients	  and	  they	  tended	  to	  present	  with	  more	  advanced	  disease,	  but	  the	  overall	  survival	  rate	  was	  the	  same4.	  Treatment	  modalities	  have	  been	  studied	  extensively	  over	  the	  past	  25	  years.	  The	  National	  Wilms	  Tumour	  Study	  Protocol	  (NWTS)	  and	  the	  Société	  International	  D’Oncologie	  Pédiatrique	  Protocol	  (SIOP)	  are	  currently	  the	  2	  most	  common	  protocols	  being	  used	  globally.	  The	  NWTS	  protocol	  stipulates	  surgery	  upfront,	  followed	  by	  neo-­‐adjuvant	  chemotherapy,	  while	  the	  SIOP	  protocol	  begins	  with	  chemotherapy	  after	  which	  surgery	  is	  performed.	  Management	  of	  Wilm’s	  tumor	  was	  researched	  previously	  in	  a	  developing	  country	  (India)	  comparing	  the	  two	  protocols	  showing	  equivalent	  clinical	  outcomes.5	  	  At	  Tygerberg	  Hospital	  in	  Cape	  Town,	  South	  Africa,	  the	  NWTS	  protocol	  was	  initially	  used	  (from	  1983),	  but	  in	  1989	  it	  was	  decided	  to	  change	  the	  protocol	  to	  SIOP.	  The	  rationale	  for	  using	  a	  different	  protocol	  was	  based	  on	  the	  clinical	  presentations	  of	  the	  children:	  	  large	  tumours	  at	  diagnosis,	  advanced	  disease	  and	  plans	  for	  a	  common	  national	  protocol.	  The	  pre-­‐operative	  chemotherapy	  is	  utilised	  to	  decrease	  the	  tumour	  volume	  in	  order	  to	  make	  surgery	  easier	  and	  to	  reduce	  the	  complication	  rate	  thereof.	  The	  aim	  of	  the	  study	  is	  to	  compare	  the	  outcome	  of	  the	  patients	  treated	  with	  the	  two	  different	  treatment	  protocols	  (SIOP	  vs	  NWTS).	  
	  
Methods	  The	  study	  population	  included	  all	  paediatric	  patients	  (<15	  years)	  diagnosed	  and	  treated	  for	  nephroblastoma	  at	  Tygerberg	  Hospital’s	  Pediatric	  Oncology	  unit	  from	  1	  January	  1983	  to	  31	  December	  2007.	  Data	  were	  collected	  from	  the	  Tygerberg	  Hospital	  tumour	  registry	  and	  from	  the	  folders	  of	  the	  patients.	  The	  following	  information	  was	  captured	  for	  each	  patient:	  date	  of	  birth,	  date	  of	  diagnosis,	  gender,	  ethnic	  group,	  staging,	  treatment	  protocol,	  surgery,	  pathology	  and	  radiotherapy	  reports,	  	  nutrition	  and	  outcome.	  	  All	  cases	  diagnosed	  were	  histologically	  confirmed	  by	  a	  pathologist	  and	  reviewed	  by	  a	  tumor	  board.	  	  The	  extracted	  data	  were	  recorded	  in	  Excel	  format.	  Descriptive	  statistics	  including	  frequency	  tables,	  histograms,	  means	  and	  standard	  deviations	  was	  performed.	  The	  survival/outcomes	  were	  demonstrated	  with	  Kaplan	  Meier	  curves	  and	  with	  the	  use	  of	  Gehan’s	  Wilcoxon	  Test	  the	  p-­‐	  values	  were	  calculated.	  A	  p-­‐value	  of	  <0.01	  were	  chosen	  as	  significant	  before	  the	  data	  was	  analyzed.	  Chi	  square	  or	  test	  calculations	  were	  used	  to	  determine	  if	  there	  is	  a	  difference	  between	  expected	  and	  measured	  data	  in	  more	  than	  one	  category.	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Ethical	  Approval	  Ethical	  approval	  for	  this	  study	  was	  obtained	  from	  the	  Health	  Research	  Ethics	  Committee	  of	  the	  University	  of	  Stellenbosch.	  The	  superintendent	  of	  Tygerberg	  Hospital	  approved	  the	  retrieval	  of	  data	  from	  the	  Tygerberg	  Hospital	  folders.	  Confidentiality	  of	  the	  patients	  was	  maintained	  at	  all	  times	  Individual	  consent	  was	  not	  required	  as	  it	  was	  a	  descriptive	  retrospective	  study.	  	  
Results	  
Location	  Tygerberg	  Hospital	  is	  a	  tertiary	  hospital	  located	  in	  Parow,	  Cape	  Town,	  serving	  the	  Eastern	  Metropolitan	  region	  of	  Cape	  Town	  and	  the	  North-­‐Eastern	  districts	  of	  the	  Western	  Cape	  Province.	  	  The	  hospital	  was	  officially	  opened	  in	  1976	  and	  provides	  healthcare	  to	  over	  3.6	  million	  people	  (2.4	  million	  children)	  being	  the	  largest	  hospital	  in	  the	  Western	  Cape	  and	  the	  second	  largest	  hospital	  in	  South	  Africa.	  The	  patients	  in	  this	  study	  came	  from	  the	  Tygerberg	  Hospital’s	  drainage	  area	  (Western	  Cape	  61%),	  followed	  by	  Namibia,	  Northern	  Cape	  and	  Eastern	  Cape	  provinces.	  	  
Ethnicity	  South	  Africa	  consists	  of	  a	  diverse	  population	  in	  terms	  of	  ethnicity	  but	  this	  can	  broadly	  be	  classified	  into	  Black,	  White	  or	  Caucasian	  and	  coloured	  or	  Mixed	  ethnicity.	  The	  Coloured	  population	  genetically	  consists	  of	  an	  ancestral	  mix	  between	  European	  and	  various	  Southern	  African	  Black	  tribes.	  This	  ethnic	  group	  is	  widespread	  across	  South	  Africa	  but	  there	  is	  a	  higher	  concentration	  of	  this	   p o p u l a t i o n 	   group	  specifically	  in	  the	  Western	  Cape	  region.	  The	  percentage	  distribution	  of	  ethnic	  groups	  shows	  32.9%	  blacks,	  48.8%	  coloured,	  15.7%	  whites,	  and	  1%	  Asian/Indian.	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Staging	  and	  diagnosis	  All	  patients	  were	  staged	  according	  to	  the	  international	  guidelines5.	  	  The	  staging	  of	  nephroblastoma	  was	  based	  on	  abdominal	  ultrasound,	  chest	  radiography,	  abdominal	  and	  chest(if	  indicated)	  computerized	  tomography	  (CT	  scan).The	  staging	  was	  completed	  after	  surgery	  with	  a	  pathology	  report.	  Associations	  between	  survival,	  stage	  of	  disease	  and	  ethnic	  group	  were	  assessed.	  	  Stage	  1	  disease	  was	  most	  common	  at	  presentation	  (37%),	  followed	  by	  stage	  3	  (24%)	  and	  stage	  4(21%)	  disease	  for	  the	  whole	  group.	  Pathology	  data	  from	  	  only	  38	  patients	  was	  analysed.	  Most	  of	  the	  pathology	  reports	  were	  old	  printed	  copies	  and	  could	  not	  be	  read	  and	  some	  copies	  were	  missing	  from	  records.The	  average	  tumour	  volume	  in	  the	  SIOP	  was	  considerably	  smaller	  613cm3	  	  	  than	  in	  the	  NWTS	  group	  1004cm3	  	  due	  to	  the	  preoperative	  chemotherapy	  effect.	  
Protocols	  and	  outcome	  	  Patients	  were	  treated	  according	  to	  NWTS	  protocol	  from	  1983-­‐	  1989	  and	  according	  to	  the	  SIOP	  protocol	  from	  1989	  onwards.	  There	  were	  39	  cases	  (39%)	  in	  the	  first	  group	  and	  59	  cases	  (61%)	  in	  the	  second	  group.	  There	  were	  50	  patients	  who	  received	  curative	  radiotherapy.	  The	  average	  ionized	  radiation	  used	  were	  27	  GY	  (gray),	  ranging	  from	  9-­‐51GY	  over	  a	  3-­‐4	  week	  period	  (as	  per	  protocol).	  	  The	  overall	  survival	  for	  the	  whole	  group	  was	  76.5%	  irrespective	  of	  the	  treatment	  protocol	  used.There	  was	  no	  statistically	  significant	  difference	  between	  male	  and	  female	  (75%	  of	  males	  and	  78%	  of	  females).	  Overall	  survival	  between	  different	  ethnic	  groups	  was	  similar:	  76.5%	  for	  the	  coloured	  population,	  78.6%	  for	  the	  whites	  and	  75.8%	  for	  the	  black	  patients	  (fig	  1).	  The	  outcome	  of	  patients	  with	  stage	  1	  and	  2	  approaches	  the	  values	  reported	  in	  developed	  countries:	  81.6%	  and	  93.3%	  respectively.	  Less	  rewarding	  results	  were	  obtained	  after	  the	  treatment	  of	  stage	  3	  and	  4	  75%	  and	  57%	  respectively.	  (fig	  2).	  Patients	  (2)	  with	  stage	  V	  were	  not	  analysed	  due	  to	  missing	  information.	  The	  overall	  survival	  for	  early	  stages	  (1	  and	  2)	  varied	  between	  80%	  for	  whites,	  82%	  for	  the	  colored	  population	  and	  88%	  for	  the	  black	  children.	  The	  outcome	  for	  stages	  3	  and	  4	  for	  the	  blacks	  was	  69%,	  for	  the	  colored	  group	  64%	  and	  75%	  for	  the	  whites,	  No	  statistical	  significance	  could	  be	  demonstrated.	  Comparing	  the	  groups	  treated	  with	  the	  2	  protocols,	  the	  distribution	  of	  stages	  was	  similar:	  both	  groups	  had	  54%	  of	  the	  patients	  with	  stage	  1	  and	  2	  disease	  and	  46%	  of	  patients	  with	  stage	  3	  and	  4	  disease.	  	  Comparing	  the	  outcome	  between	  the	  2	  groups,	  the	  survival	  for	  all	  stages	  in	  NWTS	  was	  61.5%	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  and	  86.4%	  for	  SIOP	  with	  marked	  difference	  between	  the	  stages	  (fig	  3,	  fig	  4)	  with	  a	  p-­‐value	  of	  0.002.	  The	  analysis	  of	  nutritional	  status	  showed	  that	  7.5%	  of	  patients	  in	  the	  SIOP	  group	  were	  underweight	  for	  age	  compared	  to	  2.8%	  in	  the	  NWTS	  group	  (underweight	  for	  age	  =	  weight	  between	  -­‐2	  and	  -­‐3	  Z	  score).	  The	  weights	  of	  12	  patients	  in	  the	  SIOP	  group	  and	  2	  patients	  in	  the	  NWTS	  group	  were	  unavailable.	  	  
Discussion	  Nephroblastoma	  is	  a	  common	  childhood	  tumour	  in	  Africa7	  and	  has	  in	  developed	  countries	  a	  good	  prognosis	  if	  treated	  early.	  The	  overall	  survival	  approaches	  90%	  in	  developed	  countries.	  In	  developing	  countries,	  for	  a	  variety	  of	  reasons	  the	  survival	  rates	  seldom	  approach	  these	  figures8,9	  .	  Moreira	  et	  al	  found	  an	  overall	  5	  year	  survival	  in	  Sub	  Saharan	  Africa	  of	  71%3.	  Most	  patients	  in	  developing	  countries,	  especially	  Sub-­‐Saharan	  Africa,	  present	  late	  due	  to	  limited	  access	  and	  poor	  health	  care	  fascilities,	  	  poor	  education	  and	  the	  paucity	  of	  adequate	  trained	  medical	  staff	  and	  this	  has	  a	  direct	  effect	  on	  outcome.	  	  Associated	  co-­‐morbidities	  that	  has	  a	  high	  prevalence	  eg.	  tuberculosis,	  HIV,	  malaria	  and	  malnutrition	  also	  has	  an	  effect	  on	  the	  presentation	  and	  outcome	  of	  disease	  in	  these	  countries10.	  As	  mentioned	  above	  early	  presentation	  is	  vital	  for	  a	  good	  outcome.	  	  There	  are	  no	  published	  studies	  to	  compare	  the	  2	  common	  protocols	  used	  for	  the	  treatment	  of	  the	  African	  child	  with	  Wilms	  tumor.	  In	  our	  study	  there	  were	  slightly	  more	  females	  than	  male	  patients.	  	  Reports	  have	  shown	  that	  there	  is	  a	  varying	  male	  to	  female	  ratio	  that	  ranges	  	  from	  2:3	  	  to	  1:1	  10,11	  .	  The	  median	  age	  of	  children	  with	  nephroblastoma	  is	  reported	  to	  be	  42	  months	  of	  age8	  which	  is	  the	  same	  as	  our	  median	  age	  of	  44	  months.	  	  A	  similar	  South	  African	  study	  showed	  a	  median	  age	  of	  39	  months11.	  There	  is	  a	  study	  from	  the	  GFAOP	  (Groupe	  Franco-­‐Africain	  d'Oncologie.	  Pédiatrique)	  group	  who	  report	  a	  median	  age	  of	  only	  36	  months	  in	  their	  cohort	  of	  patients3.	  	  The	  racial	  distribution	  of	  our	  patients	  reflects	  the	  population	  of	  South	  Africa	  and	  is	  representative	  of	  Western	  Cape.	  It	  is	  stated	  in	  the	  literature	  that	  nephroblastoma	  is	  more	  common	  in	  Africa	  than	  in	  developed	  countries7.	  	  Stage,	  with	  histology,	  is	  one	  of	  the	  two	  most	  important	  predictors	  of	  prognosis	  and	  survival	  in	  children	  with	  nephroblastoma12	  .	  Stage	  1	  and	  2	  disease	  are	  classified	  as	  local	  disease	  and	  when	  using	  the	  NWTS	  protocol	  can	  be	  resected	  completely.	  These	  tumours	  have	  a	  good	  prognosis	  of	  >90%	  5	  year	  survival	  in	  developed	  countries	  and	  in	  Sub	  Saharan	  Africa	  >76%	  as	  per	  Moreira	  et	  al3.	  	  Unfavourable	  histology(anaplasia)	  has	  a	  poor	  overall	  survival	  	  of	  37-­‐82%	  compared	  to	  favourable	  histology	  overall	  survival	  of	  86-­‐98%14.	  	  This	  study	  did	  not	  gather	  data	  on	  the	  histology	  of	  the	  operative	  specimens	  but	  data	  on	  the	  staging	  was	  obtained.	  Stage	  1	  disease	  was	  most	  common	  at	  presentation	  (37%),	  followed	  by	  stage	  3	  (24%)	  and	  stage	  4(21%)	  disease	  for	  the	  whole	  group.	  This	  differs	  from	  other	  figures	  from	  other	  African	  countries	  which	  quote	  that	  over	  70%	  of	  their	  patients	  had	  advanced	  stage	  at	  presentation10.	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The	  study	  of	  the	  GFAOP3	  showed	  an	  incidence	  of	  stage	  1	  disease	  of	  34%	  while	  advanced	  stage	  disease	  only	  accounted	  for	  40%	  of	  their	  patients.	  The	  two	  different	  treatment	  strategies	  which	  are	  widely	  accepted	  and	  used	  internationally	  SIOP	  and	  NWTS	  showed	  previously	  similar	  outcome	  results.5	  	  In	  this	  study	  the	  group	  treated	  according	  to	  the	  SIOP	  protocol	  had	  a	  significantly	  better	  outcome	  than	  the	  NWTS	  patient	  group,	  especially	  for	  the	  patients	  with	  stages	  1	  and	  2	  disease	  (91%	  versus	  76%).	  Patients	  with	  stage	  3	  and	  4	  disease	  in	  the	  SIOP	  group	  had	  a	  survival	  rate	  of	  82%	  versus	  43%	  for	  the	  NWTS	  group.	  The	  SIOP	  group	  had	  a	  better	  outcome	  than	  the	  NWTS	  group	  (p	  value	  0.001).	  Most	  of	  our	  patients	  were	  treated	  according	  to	  the	  SIOP	  protocol	  (61%).	  Gender	  and	  race	  did	  not	  influence	  the	  outcome	  which	  is	  for	  the	  first	  time	  described	  in	  the	  literature	  for	  an	  African	  population.	  A	  study	  from	  Poole13	  showed	  that	  their	  stage	  4	  survival	  rate	  using	  SIOP	  was	  of	  approximately	  about	  45%,	  while	  another	  South	  African	  study11	  using	  NWTS	  had	  a	  survival	  rate	  of	  54%.	  	  Our	  two	  groups	  analysed	  had	  an	  equal	  distribution	  of	  stage	  of	  presentation.	  	  The	  average	  tumour	  volume	  in	  the	  NWTS	  group	  was	  significantly	  larger	  than	  in	  the	  SIOP	  group	  (1004cm3	  compared	  to	  613cm3)	  since	  the	  SIOP	  group	  received	  pre-­‐operative	  chemotherapy.	  Surgical	  complications	  with	  tumor	  spillage	  did	  not	  contribute	  to	  the	  upstaging	  of	  the	  tumor	  and	  there	  was	  no	  significant	  change	  in	  surgical	  methods	  during	  the	  study	  time	  period.	  Nutritional	  status	  did	  not	  influence	  the	  outcome	  although	  more	  patients	  were	  underweight	  for	  age	  in	  the	  SIOP	  group.	  There	  were	  no	  major	  demographic	  differences	  between	  the	  two	  patient	  groups.	  On	  analysis	  of	  the	  patients’	  nutritional	  status,	  it	  was	  found	  that	  they	  were	  mostly	  malnourished	  with	  more	  patients	  being	  underweight	  in	  the	  SIOP	  group,	  but	  that	  did	  not	  have	  any	  effect	  on	  the	  outcome.	  Not	  enough	  information	  was	  available	  to	  correlate	  the	  pathology	  risk	  protocol	  with	  the	  outcome.	  Pathology	  reporting	  has	  changed	  and	  become	  more	  sophisticated	  over	  the	  years	  and	  thus	  could	  have	  had	  an	  effect	  on	  the	  results.	  Anaplasia	  which	  often	  leads	  to	  chemotherapy	  resistance	  was	  identified	  in	  only	  2	  patients,	  one	  in	  each	  group.	  	  Protocols	  were	  followed	  correctly	  in	  all	  cases	  analyzed	  and	  there	  was	  no	  evidence	  to	  suggest	  deviation	  from	  the	  protocols	  used.	  All	  patients	  had	  chemo-­‐	  and	  radiotherapy	  as	  per	  protocol.	  Supportive	  care	  could	  have	  played	  a	  role	  in	  the	  improved	  outcome	  in	  more	  recent	  years	  when	  the	  SIOP	  protocol	  was	  used,	  but	  this	  is	  difficult	  to	  quantify.	  There	  were	  no	  major	  changes	  in	  the	  supportive	  care	  provided	  to	  the	  two	  patient	  groups.	  	  This	  study	  confirms	  that	  gender	  and	  race	  did	  not	  influence	  the	  patient	  outcome.	  The	  data	  shows	  that	  the	  main	  variable	  affecting	  outcome	  is	  the	  stage	  of	  presentation	  and	  the	  protocol	  used.	  The	  only	  factor	  that	  remained	  a	  significant	  predictor	  of	  death	  was	  the	  treatment	  protocol	  used,	  which	  was	  previously	  not	  described.	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Possible	  reasons	  for	  the	  difference	  in	  results	  in	  comparison	  to	  the	  literature	  include	  differences	  in	  demographic	  and	  genetic	  characteristics,	  nutritional	  status,	  tumour	  volume,	  pathology	  risk	  reporting	  protocols	  in	  the	  different	  eras,	  improvement	  in	  surgical	  skills,	  as	  well	  as	  protocol	  deviation	  and	  supportive	  care.	  	  No	  genetic	  testing	  was	  available	  at	  Tygerberg	  hospital	  during	  the	  study	  period,	  thus	  this	  could	  not	  be	  investigated	  further.	  
Limitations	  of	  the	  study	  There	  are	  a	  number	  of	  limitations	  to	  the	  study.	  The	  data	  only	  represents	  children	  seen	  at	  Tygerberg	  Hospital	  pediatric	  oncology	  unit.	  This	  was	  a	  small	  retrospective	  study	  representing	  a	  specific	  population.	  Some	  patients	  were	  not	  included	  in	  this	  study	  since	  essential	  information	  was	  not	  available.	  With	  regards	  to	  the	  pathology	  reports,	  since	  reporting	  methods	  also	  changed	  during	  the	  study	  period,	  it	  complicated	  the	  interpretation	  of	  the	  tumour	  volumes.	  In	  addition,	  only	  half	  of	  the	  patients’	  tumour	  volumes	  could	  be	  found.	  	  
Conclusions	  The	  result	  that	  our	  patient	  population	  has	  a	  better	  outcome	  when	  treated	  with	  the	  SIOP	  protocol	  is	  highly	  significant	  and	  needs	  further	  research.	  This	  study	  also	  demonstrates	  that	  differences	  in	  ethnic	  group	  were	  not	  significant	  in	  the	  outcome,	  black,	  colored	  and	  white	  children	  having	  similar	  survival	  graphs	  when	  presented	  with	  the	  same	  stages.	  Larger	  studies	  are	  needed	  in	  identifying	  the	  optimal	  treatment	  protocol	  for	  the	  treatment	  of	  the	  African	  children	  with	  nephroblastoma	  and	  a	  better	  characterization	  of	  the	  disease.	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Fig	  1:	  Corelation	  of	  survival	  with	  the	  ethnic	  group	  	  
	  	  Fig	  2:	  Corelation	  of	  stages	  and	  outcome	  (p-­‐value=0.01)	  	  
	  Fig	  3:	  Comparing	  the	  outcomes	  of	  the	  stages	  treated	  with	  the	  NWTS	  protocol	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